{"id":"W4399566448","doi":"10.1182/bloodadvances.2024012693","title":"Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Center for Chronic Disease Prevention and Health Promotion; National Heart, Lung, and Blood Institute; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; Seagen; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; National Center for Advancing Translational Sciences; HistoGenetics; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; University of Southern California; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Astellas Pharma; Adaptive Biotechnologies; MorphoSys; California Department of Public Health; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Centers for Disease Control and Prevention; Gateway for Cancer Research; Amgen; Incyte; Pfizer","keywords":"Cumulative incidence; Population; Medicine; Incidence (geometry); Cohort; Cancer registry; Transplantation; Hematopoietic cell; Oncology; Demography; Internal medicine; Environmental health; Biology; Mathematics; Haematopoiesis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002539787,0.0001455243,0.0002227616,0.00007942758,0.00005527912,0.00005759591,0.0001189534,0.00005035659,0.00002631684],"category_scores_gemma":[0.0004628049,0.00008698102,0.0000419571,0.0002264043,0.0002104875,0.0001714239,0.00005285501,0.0001922991,0.000009776417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001084189,"about_ca_system_score_gemma":0.0003765282,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001115253,"about_ca_topic_score_gemma":0.0002009677,"domain_scores_codex":[0.998856,0.00002481543,0.0002071035,0.0003256511,0.0002819239,0.0003044909],"domain_scores_gemma":[0.9988444,0.0008078353,0.00003606925,0.0001833627,0.00005713372,0.0000712072],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004521738,0.0009174648,0.8142145,0.01563188,0.001134056,0.008876919,0.01954165,0.001357388,0.0168104,0.002558088,0.01020944,0.1042265],"study_design_scores_gemma":[0.01942614,0.003449351,0.3834608,0.0252873,0.002468026,0.004646332,0.00779144,0.2219948,0.05106954,0.03570198,0.2423235,0.002380692],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9304109,0.06325912,0.0009602904,0.00354956,0.0001187393,0.0009289631,0.0001916145,0.00006693273,0.0005139022],"genre_scores_gemma":[0.9953051,0.0008957688,0.00217433,0.0005105891,0.0002039633,0.0006071151,0.00001060354,0.00002277593,0.0002698172],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4307536,"threshold_uncertainty_score":0.3546983,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01571897578083386,"score_gpt":0.356687035706387,"score_spread":0.3409680599255532,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}